Dr. Gerber welcomes email inquiries regarding opportunities for post-doctoral training in his laboratory.
Anthony N. Gerber, MD, PhD
University of California, San Francisco Pulmonary and Critical Care Fellowship, 2001-2005
University of California, San Francisco Internal medicine resident 1998-2001
University of Washington, MD, PhD, 1998
Massachusetts Institute of Technology, BS, 1990
Dr. Anthony N. Gerber completed MD and PhD degrees at the University of Washington and post-graduate medical training in pulmonary and critical care medicine at the University of California, San Francisco. His clinical interests are cough and obstructive lung disease. Complementing this clinical interest, Dr. Gerber's research program is focused on uncovering the molecular mechanisms whereby glucocorticoids, a major therapy for treating obstructive lung disease, exert their clinical effects.
Sarah Sasse, PhD
Staff Research Faculty Member
University of Colorado, Boulder, PhD, Psychology and Neuroscience, 2009;
University of Colorado, Boulder, MA, Psychology, 2006;
University of Colorado, Boulder, BA, Psychology 2002
Sarah Sasse graduated with a PhD in Psychology and Neuroscience in 2009 and began her postdoctoral fellowship in the new laboratory of Dr. Anthony Gerber several months thereafter. While much of her graduate work involved exploring the neural circuitry and biochemical mechanisms underlying the initiation, adaptation, and modification of endogenous glucocorticoid-mediated stress responses, Dr. Sasse is now using the glucocorticoid receptor (GR) as a tool for identifying genes and elucidating their specific roles in mediating therapeutic effects in airway smooth muscle, a key target of structural and functional pathology in asthma. Current projects include: 1) exploring the temporal dynamics of the GR-regulated transcriptome through quantifying GR-induced changes in nascent transcription rates, and 2) studying the role of the GR target gene, Klf15, in airway function and as a downstream mediator of the GR response in vivo using smooth muscle-specific knockout and transgenic mice.
Fabienne Gally, PhD
University J. Fourier (Grenoble, France), PhD, Molecular and Cellular Electrophysiology
Fabienne Gally, PhD, is a researcher at National Jewish Health. Dr. Gally is in the Department of Immunology and Genomic Medicine. Her research areas include basic immunology, cellular and molecular biology, inflammation, innate immunity, lung cell biology, asthma and COPD. Dr. Gally studies lung host defense mechanisms in COPD. Particularly, she focuses on revealing the mechanisms underlying the increased susceptibility to respiratory bacterial infections in COPD.
Arnav Gupta, MD